Mannan-binding lectin: Clinical significance and applications

Biochimica et Biophysica Acta - General Subjects

Volumn 1572, Issue 2-3, 2002, Pages 401-413

  Kilpatrick, David C ^a  

^a SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

Author keywords

Collectin; Innate immunity; Mannan binding lectin; Mannose binding lectin; Opsonization

Indexed keywords

MANNAN BINDING LECTIN; PROTEIN; SERINE PROTEINASE;

ALLELE; BLOOD FLOW; BLOOD LEVEL; CLINICAL CHEMISTRY; DISEASE PREDISPOSITION; GENE STRUCTURE; GENOTYPE; HAPLOTYPE; HUMAN; IMMUNITY; INFECTION; LIVER METABOLISM; MOLECULE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVIEW;

ALLELES; ANIMALS; ARTHRITIS, RHEUMATOID; BACTERIAL INFECTIONS; CARRIER PROTEINS; CLINICAL TRIALS; COLLECTINS; COMPLEMENT ACTIVATION; CYSTIC FIBROSIS; GENOTYPE; HUMANS; IMMUNOCOMPROMISED HOST; LUPUS ERYTHEMATOSUS, SYSTEMIC; MYCOSES; VIRUS DISEASES;

EID: 0037136413     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(02)00321-5     Document Type: Review

References (131)

1. Miller M.E., Seals J., Kaye R., Levitsky L.C. A familial plasma-associated defect of phagocytosis. Lancet. 2:1968;60-63.
2. Richardson V.F., Larcher V.F., Price J.F. A common congenital immunodeficiency predisposing to infection and atopy in infancy. Arch. Dis. Child. 58:1983;799-802.
3. Robinson D., Phillips N.C., Winchester B. Affinity chromatography of human liver α-D-mannosidase. FEBS Lett. 53:1975;110-112.
4. Kawasaki T., Etoh R., Yamashina I. Isolation and characterization of a mannan-binding protein from rabbit liver. Biochem. Biophys. Res. Commun. 81:1978;1018-1024.
5. Kozutsumi Y., Kawasaki T., Yamashina I. Isolation and characterization of a mannan-binding protein from rabbit serum. Biochem. Biophys. Res. Commun. 95:1980;658-664.
6. Kawasaki N., Kawasaki T., Yamashina I. Isolation and characterization of a mannan-binding protein from human serum. J. Biochem. 94:1983;937-947.
7. Wild J., Robinson D., Winchester B. Isolation of mannose-binding proteins from human and rat liver. Biochem. J. 210:1983;167-174.
8. Drickamer K., Dordal M.S., Reynolds L. Mannose-binding proteins isolated from rat liver contain carbohydrate-recognition domains linked to collagenous tails. J. Biol. Chem. 261:1986;6878-6887.
9. Super M., Lu J., Thiel S., Levinsky R.J., Turner M.W. Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet. 2:1989;1236-1239.
10. Sumiya M., Super M., Tabona P., Levinsky R.J., Arai T., Turner M.W., Summerfield J.A. Molecular basis of opsonic defect in immunodeficient children. Lancet. 337:1991;1569-1570.
11. Van Damme E.J.M., Peumans W.J. Lectins from Monocotyledonae. Kilpatrick D.C., Van Driessche E., Bøg-Hansen T.-C. Lectin Reviews. vol. 1:1991;161-170 Sigma, St. Louis.
12. Loris R. Principles of structures of animal and plant lectins. Biochim. Biophys. Acta. 1572:2002;198-208.
13. Lu J., Teh C., Kishore U., Reid K.B.M. Collectins and ficolins: sugar pattern recognition molecules of the mammalian innate immune system. Biochim. Biophys. Acta. 1572:2002;387-400.
14. Yakota Y., Arai T., Kawasaki T. Oligomeric structures required for complement activation of serum mannan-binding proteins. J. Biochem. 117:1995;414-419.
15. Kilpatrick D.C. Mystery plasma lectin was a contaminant. Transfus. Med. 8:1998;239.
16. Gabius H.-J., André S., Kaltner H., Siebert H.-C. The sugar code: functional lectinomics. Biochim. Biophys. Acta. 1572:2002;165-177.
17. Hansen S., Holmskov U. Structural aspects of collectins and receptors for collectins. Immunobiology. 199:1998;165-189.
18. 2 complex, of the classical pathway of complement, without involvement of C1q. J. Immunol. 144:1990;2287-2294.
19. Lipscombe R.J., Sumiya M., Summerfield J.A., Turner M.W. Distinct physiochemical characteristics of human mannose binding protein expressed by individuals of differing genotype. Immunology. 85:1995;660-667.
20. Turner M.W. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol. Today. 17:1996;532-540.
21. Kawasaki T. Structure and biology of mannan-binding protein, MBP, an important component of innate immunity. Biochim. Biophys. Acta. 1473:1999;186-195.
22. Peterson S.V., Thiel S., Jensenius J.C. The mannan-binding lectin pathway of complement activation: biology and disease association. Mol. Immunol. 38:2001;133-149.
23. Rossi V., Cseh S., Bally I., Thielens N.M., Jensenius J.C., Arlaud G.J. Substrate specificities of recombinant mannan-binding lectin-associated serine proteases-1 and -2. J. Biol. Chem. 276:2001;40880-40887.
24. Ikeda K., Sannoh T., Kawasaki N., Kawasaki T., Yamashina I. Serum lectin with a known structure activates complement through the classical pathway. J. Biol. Chem. 262:1987;7451-7454.
25. Yokata Y., Arai T., Kawasaki T. Oligomeric structures required for complement activation of serum mannan-binding proteins. J. Biochem. 11:1995;414-419.
26. Thiel S., Holmskov U., Hviid L., Laursen S.B., Jensenius J.C. The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase response. Clin. Exp. Immunol. 90:1992;31-35.
27. Hansen T.K., Thiel S., Dall R., Rosenfalck A.M., Trainer P., Flyvbjerg A., Jorgensen J.O.L., Christiansen J.S. GH strongly affects serum concentrations of mannan-binding lectin: evidence for a new IGF-independent immunodulatory effect of GH. J. Clin. Endocrinol. Metab. 86:2001;5383-5388.
28. Madsen H.O., Garred P., Kurtzhals J.A.L., Lamm L.U., Ryder L.P., Thiel S., Svejgaard A. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding gene. Immunogenetics. 40:1994;37-44.
29. Crosdale D.J., Ollier W.E.R., Thomson W., Dyer P.A., Jensenius J., Johnson R.W.G., Poulton K.V. Mannose-binding lectin (MBL) genotype distributions with relation to serum levels in UK Caucasoids. Eur. J. Immunogenet. 27:2000;111-117.
30. Kruse C., Rosgaard A., Steffensen R., Varming K., Jensenius J.C., Christiansen O.B. Low serum level of mannan-binding lectin is a determinant for pregnancy outcome in women with recurrent spontaneous abortion. Am. J. Obstet. Gynecol. 2002;. in press.
31. Summerfield J.A., Sumiya M., Levin M., Turner M.W. Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. Br. Med. J. 314:1997;1229-1232.
32. Koch A., Melbye M., Sørensen P., Homøe P., Madsen H.O., Molbak K., Hansen C.H., Andersen L.H., Hahn G.W., Garred P. Acute respiratory tract infections and mannose binding lectin insufficiency during early childhood. J. Am. Med. Assoc. 285:2001;1316-1321.
33. Garred P., Madsen H.O., Hofmann B., Svejgaard A. Increased frequency of homozygosity of abnormal mannan-binding-protein alleles in patients with suspected immunodeficiency. Lancet. 346:1995;941-943.
34. Aittoniemi J., Baer M., Soppi E., Vesikari T., Miettinen A. Mannan binding lectin deficiency and concomitant immunodefects. Arch. Dis. Child. 78:1998;245-248.
35. Neonato M.G., Lu C.Y., Guilloud-Bataille M., Lapoumeroulie C., Nabeel-Jassim H., Dabit D., Girot R., Krishnamoorthy R., Feingold J., Besmond C., Elion J. Genetic polymorphism of the mannose-binding protein gene in children with sickle-cell disease: identification of three new variant alleles and relationships to infections. Eur. J. Hum. Genet. 7:1999;679-686.
36. Homoe P., Madsen H.O., Sandvej K., Koch A., Garred P. Lack of association between mannose-binding lectin, acute otitis media and early Epstein-Barr virus infection among children in Greenland. Scand. J. Infect. Dis. 31:1999;363-366.
37. Ten R.M., Carmona E.M., Babovic-Vuksanovic D., Katzmann J.A. Mannose-binding lectin deficiency associated with neutrophil chemotactic unresponsiveness to C5a. J. Allergy Clin. Immmunol. 104:1999;419-424.
38. Summerfield J.A., Ryder S., Sumiya M., Thursz M., Gorchein A., Monteil M.A., Turner M.W. Mannose binding protein gene mutations associated with unusual and severe infection in adults. Lancet. 345:1995;886-889.
39. Kakkanaiah V.N., Shen G.Q., Ojo-Amaize E.A., Peter J.B. Association of low concentrations of serum mannose-binding protein with recurrent infections in adults. Clin. Diagn. Lab. Immunol. 5:1998;319-321.
40. Aittoniemi J., Rintala E., Miettinen A., Soppi E. Serum mannan-binding lectin (MBL) in patients with infection: clinical and laboratory correlates. APMIS. 105:1997;617-622.
41. Neth O., Hann I., Turner M.W., Klein N.J. Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study. Lancet. 358:2001;614-618.
42. Peterslund N.A., Koch C., Jensenius J.C., Thiel S. Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet. 358:2001;637-638.
43. Ezekowitz R.A.B., Kuhlman M., Groopman J.E., Byrn R.A. A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J. Exp. Med. 169:1989;185-196.
44. Saifuddin M., Hart M.L., Gewurz H., Zhang Y., Spear G.T. Interaction of mannose-binding lectin with primary isolates of human immunodeficiency virus type 1. J. Gen. Virol. 81:2001;949-955.
45. Nielsen S.L., Andersen P.L., Koch C., Kensenius J.C., Thiel S. The level of the serum opsonin, mannan-binding protein in HIV-1 antibody-positive patients. Clin. Exp. Immunol. 100:1995;219-222.
46. Garred P., Madsen H.O., Balslev U., Hofmann B., Pedersen C., Gerstoft J., Svejgaard A. Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin. Lancet. 349:1997;236-240.
47. Garred P., Richter C., Anderson A.B., Madsen H.O., Mtoni I., Svejgaard A., Shao J. Mannan-binding lectin in the sub-Saharsn HIV and tuberculosis epidemics. Scand. J. Immunol. 46:1997;204-208.
48. Pastinin T., Liitsola K., Niini P., Salminen M., Syvänen A.-C. Contribution of the CCR5 and MBL genes to susceptibility to HIV type 1 infection in the Finnish population. AIDS Res. Hum. Retrovir. 14:1998;695-698.
49. Prohaszka Z., Thiel S., Ujhelyi E., Szlavik J., Banhegyi D., Fust G. Mannan-binding lectin serum concentrations in HIV-infected patients are influenced by the stage of disease. Immunol. Lett. 58:1997;171-175.
50. Amoroso A., Berrino M., Boniotto M., Crovella S., Palomba E., Scarlatti G., Serra C., Tovo P.-A., Vatta S. Polymorphism at codon 54 of mannose-binding protein gene influences AIDS progression but not HIV infection in exposed children. AIDS. 13:1999;863-864.
51. Senaldi G., Davies E.T., Mahalingam M., Lu J., Pozniak A., Peakman M., Reid K.B.M., Vergani D. Circulating levels of mannose binding protein in human immunodeficiency virus infection. J. Infect. 31:1995;145-148.
52. Maas J., Husman A.-M., Brouwer M., Krol A., Coutinho R., Kreet I., van Leeuwen R., Schuitemaker H. Presence of the variant mannose-binding lectin alleles associated with slower progression to AIDS. AIDS. 12:1998;2275-2280.
53. Kelly P., Jack D.L., Naeem A., Mandanda B., Pollok R.C.G., Klein N.J., Turner M.W., Farthing M.J.G. Mannose-binding lectin is a component of innate mucosal defense against Cryptosporidium parvum in AIDS. Gastroenterology. 119:2000;1236-1242.
54. Hundt M., Heiken H., Schmidt R.E. Association of low mannose-binding lectin serum concentrations and bacterial pneumonia in HIV infection. AIDS. 14:2000;1853-1854.
55. Thomas H.C., Foster G.R., Sumiya M., McIntosh D., Jack D.L., Turner M.W., Summerfield J.A. Mutation of gene for mannose-binding protein associated with chronic hepatitis B viral infection. Lancet. 348:1996;1417-1419.
56. Hohler T., Wunschlel M., Gerken G., Schneider P.M., zum Buschenfelde K.H.M., Rittner C. No association between mannose-binding lectin alleles and susceptibility to chronic hepatitis B virus infection in German patients. Exp. Clin. Immunogenet. 15:1998;130-133.
57. Bellamy R., Ruwende C., McAdam K.P.W.J., Thursz M., Sumiya M., Summerfield J., Gilbert S.C., Corrah T., Kwiatkowski D., Whittle H.C., Hill A.V.S. Mannose binding protein deficiency is not associated with malaria, hepatitis B carriage nor tuberculosis in Africans. Q. J. Med. 91:1998;13-18.
58. Yuen M.F., Lau C.S., Lau Y.L., Wong W.M., Cheng C.C., Lai C.L. Mannose binding lectin gene mutations are associated with progression of liver disease in chronic hepatitis B infection. Hepatology. 29:1999;1248-1251.
59. Matsushita M., Hijikata M., Matsushita M., Ohta Y., Mishiro S. Association of mannose-binding lectin gene haplotype LXPA and LYPB with interferon-resistant hepatitis C virus infection. J. Hepatol. 29:1998;695-700.
60. Sasaki K., Tsutsumi A., Wakamuya N., Ohtani K., Suzuki Y., Watanabe Y., Nakayama N., Koike T. Mannose-binding lectin polymorphisms in patients with hepatitis C virus infection. Scand. J. Gastroenterol. 35:2000;960-965.
61. Endo M., Ohsawa I., Ohi H., Fujita T., Matsushita M., Fujita T. Mannose-binding lectin contributes to glomerulonephritis induced by hepatitis C virus infection. Nephron. 87:2001;374-375.
62. Hartshorn K.L., Sastry K., White M.R., Anders E.M., Super M., Ezekowitz R.A., Tauber A.I. Human mannose-binding protein functions as an opsonin for influenza A viruses. J. Clin. Invest. 91:1993;1414-1420.
63. Malhotra R., Haurum J.S., Thiel S., Sim R.B. Binding of human collectins (SP-A and MBP) to influenza virus. Biochem. J. 304:1994;455-461.
64. Anders E.M., Hartley C.A., Reading P.C., Ezekowitz R.A.B. Complement-dependent neutralization of influenza virus by a serum mannose-binding lectin. J. Gen. Virol. 75:1994;615-622.
65. Kase T., Suzuki Y., Kawai T., Sakamoto T., Ohtani K., Eda S., Maeda A., Okuno Y., Kurimura T., Wakamiya N. Human mannan-binding lectin inhibits the infection of influenza A virus without complement. Immunology. 97:1999;385-392.
66. Hartshorn K.L., White M.R., Shepherd V., Reid K., Jensenius J.C., Crouch E.C. Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum collectins. Am. J. Physiol., Lung Cell. Mol. Physiol. 17:1997;L1156-L1166.
67. Neth O., Jack D.L., Dodds A.W., Holzel H., Klein N.J., Turner M.W. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect. Immun. 68:2000;688-693.
68. Townsend R., Read R.C., Turner M.W., Klein N.J., Jack D.L. Differential recognition of obligate anaerobic bacteria by human mannose-binding lectin. Clin. Exp. Immunol. 124:2001;223-228.
69. Jack D.L., Dodds A.W., Anwar N., Ison C.A., Law A., Frosch M., Turner M.W., Klein N.J. Activation of complement by mannose-binding lectin on isogenic mutants of Neisseria meningitidis serogoup B. J. Immunol. 160:1998;1346-1353.
70. Jack D.L., Jarvis G.A., Booth C.L., Turner M.W., Klein N.J. Mannose-binding lectin accelerates complement activation and increases serum killing of Neisseria meningitidis serogoup C. J. Infect. Dis. 184:2001;836-845.
71. Drogari-Apiranthitou M., Fijen C.A.P., Thiel S., Platonov A., Jensen L., Dankert J., Kuijper E.J. The effect of mannan-binding lectin on opsonophagocytosis of Neisseria meningitidis. Immunopharmacology. 38:1997;93-99.
72. Garred P., Michaelsen T.E., Bjune G., Thiel S., Svejgaard A. A low serum concentration of mannan-binding protein is not associated with serogroup B or C meningococcal disease. Scand. J. Immunol. 37:1993;468-470.
73. Bax W.A., Cluysenaer O.J.J., Bartelink A.K.M., Aerts P.C., Ezekowitz R.A.B., van Dijk H. Association of familial deficiency of mannose-binding lectin and meningococcal disease. Lancet. 354:1999;1094-1095.
74. Hibberd M.L., Sumiya M., Summerfield J.A., Booy R., Levin M. the Meningococcal Research Group Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease. Lancet. 353:1999;1049-1053.
75. Jack D.L., Read R.C., Tenner A.J., Frosch M., Turner M.W., Klein N.J. Mannose-binding lectin regulates the inflammatory response of human professional phagocytes to Neisseria meningitidis serogoup B. J. Infect. Dis. 184:2001;1152-1162.
76. Jack D.L., Klein N.J., Turner M.W. Mannose-binding lectin: targeting the microbial world for complement attack and opsonophagocytosis. Immunol. Rev. 180:2001;86-99.
77. Swanson A., Ezekowitz R.A.B., Lee A., Kuo C.-C. Human mannose-binding protein inhibits infection of HeLa cells by Chlamydia trachomatis. Infect. Immun. 66:1998;1607-1612.
78. Madsen H.O., Videm V., Svejgaard A., Svennevig J.L., Garred P. Association of mannose-binding lectin deficiency with severe atherosclerosis. Lancet. 352:1998;959-960.
79. Hegele R.A., Ban M.R., Anderson C.M., Spence J.D. Infection-susceptibility alleles of mannose-binding lectin are associated with increased carotid plaque area. J. Investig. Med. 48:2000;198-202.
80. Luty A.J.F., Kun J.F.J., Kremsner P.G. Mannose-binding lectin plasma levels and gene polymorphisms in Plasmodium falciparum malaria. J. Infect. Dis. 178:1998;1221-1224.
81. Crosdale D.J., Poulton K.V., Ollier W.E., Thomson W., Denning D.W. Mannose-binding lectin gene polymorphisms as a susceptibility factor for chronic necrotizing pulmonary aspergillosis. J. Infect. Dis. 184:2001;653-656.
82. Klabunde J., Uhlemann A.C., Tebo A.E., Kimmel J., Schwarz R.T., Kremsner P.G., Kun J.F.J. Recognition of Plasmodium falciparum proteins by mannan-binding lectin, a component of the human innate immune system. Parasitol. Res. 88:2002;113-117.
83. Davies E.J., Snowden N., Hillarby M.C., Carthy D., Grennan D.M., Thomson W., Ollier W.E.R. Mannose-binding protein gene polymorphism in systemic lupus erythematosus. Arthritis Rheum. 38:1995;110-114.
84. Lau Y.L., Lau C.S., Chan S.Y., Karlberg J. Mannose-binding protein in Chinese patients with systemic lupus erythematosus. Arthritis Rheum. 39:1996;706-708.
85. Sullivan K.E., Wooten C., Goldman D., Petri M. Mannose-binding protein genetic polymorphisms in black patients with systemic lupus erythematosus. Arthritis Rheum. 39:1996;2046-2051.
86. Davies E.J., Teh L.-S., Ordi-Ros J., Snowden N., Hillarby M.C., Hajeer A., Donn R., Perez-Pemen P., Vilardell-Tarres M., Ollier W.E.R. A dysfunctional allele of the mannose binding protein gene associates with systemic lupus erythematosus in a Spanish population. J. Rheumatol. 24:1997;485-488.
87. Kilpatrick D.C. Handbook of Animal Lectins: Properties and Biomedical Applications. 2000;41 Wiley, Chichester.
88. Senaldi G., Davies E.T., Peakman M., Vergani D., Lu J., Reid K.B.M. Frequency of mannose binding protein deficiency in patients with systemic lupus erythematosus. Arthritis Rheum. 38:1995;1713-1714.
89. Ip W.K., Chan S.Y., Lau C.S., Lau Y.L. Association of systemic lupus erythematosus with promoter polymorphisms of the mannose-binding lectin gene. Arthritis Rheum. 41:1998;1663-1668.
90. Garred P., Madsen H.O., Halberg P., Peterson J., Kronborg G., Svejgaard A., Andersen V., Jacobsen S. Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. Arthritis Rheum. 42:1999;2145-2152.
91. Horiuchi T., Tsukamoto H., Morita C., Sawabe T., Harashima S., Nakashima H., Miyahara H., Hashimura C., Kondo M. Mannose-binding lectin (MBL) gene mutation is not a risk factor for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) in Japanese. Genes Immun. 1:2000;464-466.
92. Holders V.M. Complement deficiency states, disease susceptibility, and infection risk in systemic lupus erythematosus. Arthritis Rheum. 42:1999;2023-2025.
93. Foster C.B., Lehrnbecher T., Mol F., Steinberg S.M., Venzon D.J., Walsh T.J., Noack D., Rae J., Winkelstein J.A., Curnutte J.Y., Chanock S.J. Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease. J. Clin. Invest. 102:1998;2146-2155.
94. Mullighan C.G., Marshall S.E., Welsh K.I. Mannose-binding lectin polymorphisms are associated with early age of disease onset and autoimmunity in common variable immunodeficiency. Scand. J. Immunol. 51:2000;111-122.
95. Rademacher T.W., Williams P., Dwek R.A. Agalactosyl glycoforms of IgG autoantibodies are pathogenic. Proc. Natl. Acad. Sci. U. S. A. 91:1994;6123-6127.
96. Malhotra R., Wormald M.R., Rudd P.M., Fischer P.B., Dwek R.A., Sim R.B. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat. Med. 1:1995;237-243.
97. Kilpatrick D.C. Mannan binding protein in sera positive for rheumatoid factor. Br. J. Rheumatol. 36:1997;207-209.
98. Stanworth S.J., Donn R.P., Hassall A., Dawes P., Ollier W., Snowden N. Absence of an association between mannose-binding lectin polymorphism and rheumatoid arthritis. Br. J. Rheumatol. 37:1998;186-188.
99. Graudal N.A., Homann C., Madsen H.O., Svejaard A., Jurik A.G., Graudal H.K., Garred P. Mannan binding lectin in rheumatoid arthritis, a longitudinal study. J. Rheumatol. 25:1998;629-635.
100. Garred P., Madsen H.O., Marquart H., Hansen T.M., Sorensen S.F., Peterson J., Volck B., Svejgaard A., Graudal N.A., Rudd P.M., Dwek R.A., Sim R.B., Andersen V. Two edged role of mannose binding lectin in rheumatoid arthritis: a cross sectional study. J. Rheumatol. 27:2000;26-34.
101. Graudal N.A., Madsen H.O., Tarp U., Svejgaard A., Jurik A.G., Graudal H.K., Garred P. The association of variant mannose binding lectin genotypes with radiographic outcome in rheumatoid arthritis. Arthritis Rheum. 43:1999;515-521.
102. Ip W.K., Lau Y.L., Chan S.Y., Mok C.C., Chan D., Tong K.K., Lau C.S. Mannose binding lectin and rheumatoid arthritis in southern Chinese. Arthritis Rheum. 43:2000;1679-1687.
103. Saevarsdottir S., Vikingsdottir T., Vikingsson A., Manfredsdottir V., Geirsson A.J., Valdimarsson H. Low mannose binding lectin predicts poor prognosis in patients with early rheumatoid arthritis. A prospective study. J. Rheumatol. 28:2001;728-734.
104. Jacobson S., Madsen H.O., Klarlund M., Jensen T., Skjodt H., Jensen K.E., Svejgaard A., Garred P. the TIRA group The influence of mannose binding polymorphisms on disease outcome in early polyarthritis. J. Rheumatol. 28:2001;935-942.
105. Garred P., Pressler T., Madsen H.O., Fredericksen B., Svejgaard A., Høily N., Schwartz M., Koch C. Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J. Clin. Invest. 104:1999;431-437.
106. Gabolde M., Guilloud-Bataille M., Feingold J., Besmond C. Association of variant alleles of mannose binding lectin with severity of pulmonary disease in cystic fibrosis: cohort study. Br. Med. J. 1999;1166-1167.
107. Davies J., Neth O., Alton E., Klein N., Turner M.W. Differential binding of mannose-binding lectin to respiratory pathogens in cystic fibrosis. Lancet. 355:2000;1885-1886.
108. Worlitzsch D., Tarran R., Ulrich M., Schwab U., Cekeci A., Meyer K.C., Birrer P., Bellon G., Berger J., Weiss T., Botzenhart K., Yankaskas J.R., Randell S., Boucher R.C., Döring G. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J. Clin. Invest. 109:2002;317-325.
109. De Soyza A., McDowell A., Archer L., Dark J.H., Elbon S.J., Mahenthiralingam E., Gould K., Corris P.A. Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis. Lancet. 358:2001;1780-1781.
110. Gabolde M., Hubert D., Guilloud-Bataille M., Lenaerts C., Feingold J., Besmond C. The mannose binding lectin gene influences the severity of chronic liver disease in cystic fibrosis. J. Med. Genet. 38:2001;310-311.
111. Kilpatrick D.C., Bevan B.H., Liston W.A. Association between mannan binding protein deficiency and recurrent miscarriage. Mol. Hum. Reprod., 1 Hum. Reprod. 10:1995;2501-2505.
112. Christiansen O.B., Kilpatrick D.C., Souter V., Varming K., Thiel S., Jensenius J.C. Mannan-binding lectin deficiency is associated with unexplained recurrent miscarriage. Scand. J. Immunol. 49:1999;193-196.
113. Kilpatrick D.C., Starrs L., Moore S., Souter V., Liston W.A. Mannan binding lectin concentration and risk of miscarriage. Hum. Reprod. 14:1999;2379-2380.
114. Baxter N., Sumiya M., Cheng S., Erlich H., Regan L., Simons A., Summerfield J.A. Recurrent miscarriage and variant alleles of mannose binding lectin, tumour necrosis factor and lymphotoxin alpha genes. Clin. Exp. Immunol. 126:2001;529-536.
115. Kilpatrick D.C. Mannose binding lectin concentration during normal human pregnancy. Hum. Reprod. 15:2000;941-943.
116. Weyrich A.S., Ma X., Lefer D.J., Albertine K.H., Lefer A.M. In vivo neutralisation of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J. Clin. Invest. 91:1993;2620-2629.
117. Collard C.D., Montalto M.C., Reenstra W.R., Buras J.A., Stahl G.L. Endothelial oxidative stress activates the lectin complement pathway-role of cytokeratin 1. Am. J. Pathol. 159:2001;1045-1054.
118. Collard C.D., Vakeva A., Morrissey M.A., Agah A., Rollins S.A., Reenstra W.R., Buras J.A., Meri S., Stahl G.L. Complement activation after oxidative stress. Role of the lectin complement pathway. Am. J. Pathol. 156:2000;1549-1556.
119. Jordan J.E., Montalto M.C., Stahl G.L. Inhibitors of mannose-binding lectin reduces post-ischaemic myocardial reperfusion injury. Circulation. 104:2001;1413-1418.
120. Ma Y., Uemura K., Oka S., Kozutsumi Y., Kawasaki N., Kawasaki T. Antitumor activity of mannan-binding protein in vivo as revealed by a virus expression system: mannan-binding protein-dependent cell-mediated cytotoxicity. Proc. Natl. Acad. Sci. U. S. A. 96:1999;371-375.
121. Soothill J.F., Harvey B.A.M. Defective opsonization: a common immunity deficiency. Arch. Dis. Child. 51:1976;91-99.
122. Valdimarsson H., Stefansson M., Vikingsdottir T., Arason G.J., Koch C., Thiel S., Jensenius J.-C. Reconstitution of opsonizing activity by infusion of mannan-binding lectin (MBL) to MBL-deficient humans. Scand. J. Immunol. 48:1998;116-123.
123. Kilpatrick D.C. Isolation of human mannan binding lectin, serum amyloid P component and related factors from Cohn fraction III. Transfus. Med. 7:1997;289-294.
124. Vorup-Jensen T., Sorensen E.S., Jensen U.B., Schwaeble W., Kawasaki T., Ma Y., Uemura K., Wakamiya N., Suzuki Y., Jensen T.G., Takahashi K., Ezekowitz R.A.B., Thiel S., Jensenius J.C. Recombinant expression of human mannan-binding lectin. Int. Immunopharmacol. 1:2001;677-687.
125. Vorup-Jensen T., Jensen U.B., Lui H., Kawasaki T., Uemura K., Thiel S., Dagnaes-Hansen F., Jensen T.G. Tail-vein injection of human mannan-binding lectin DNA leads to high expression levels of multimeric protein in liver. Molec. Ther. 3:2001;867-874.
126. Matsushita M., Miyakawa H., Tanaka A., Hijikata M., Kiruchi K., Fujikawa H., Arai J., Sainokami S., Hino K., Terai I., Mishiro S., Gershwin M.E. Single nucleotide polymorphisms of the human mannose-binding lectin are associated with susceptibility to primary biliary cirrhosis. J. Autoimmun. 17:2001;251-257.
127. de Miranda Santos I.K.F., Costa C.H.N., Krieger H., Feitosa M.F., Zurakowski D., Fardin B., Gomes R.B.B., Weiner D.L., Harn D.A., Ezekowitz R.A.B., Epstein J.E. Mannan-binding lectin enhances susceptibility to visceral leishmaniasis. Infect. Immun. 69:2001;5212-5215.
128. Hoal-Van Helden E.G., Epstein J., Victor T.C., Hon D., Lewis L.-A., Beyers N., Zurakowski D., Ezekowitz R.A.B., Van Helden P.D. Mannose-binding protein B allele confers protection against tuberculosis meningitis. Pediatr. Res. 45:1999;459-464.
129. Polotsky V.Y., Belisle J.T., Mukosova K., Ezekowitz R.A.B., Joiner K.A. Interaction of human mannose-binding lectin with Mycobacterium avium. J. Infect. Dis. 175:1997;1159-1168.
130. Garred P., Richter C., Andersen A.B., Madsen H.O., Mtoni I., Svejgaard A., Shao J. Mannan-binding lectin in the sub-Saharan HIV and tuberculosis epidemics. Scand. J. Immunol. 46:1997;204-208.
131. Garred P., Harboe M., Oettinger T., Koch C., Svejgaard A. Dual role of mannan-binding protein in infections: another case of heterosis? Eur. J. Immunogenet. 21:1994;125-131.